CMAN 272 EXAM 3 HIGH-YIELD TOPICS
SUMMARY 2026
◉ Amnesia
Answer: Memory impairment
- inability to learn new information recall previously learned
information.
◉ Apraxia
Answer: Inability to carry out motor activities despite intact motor
function.
◉ decrease neuronal loss
Answer: Medication for AD aid to _____________________.
◉ Acetylcholinesterase Inhibitors
Answer: For mild to moderate AD
- Ex. Tacrine, Donepezil, Rivastigmine, Galantamine
◉ Memantine
Answer: For moderate to severe disease; the only approved
medication for Alzheimer disease that is not an AChE inhibitor.
,- SE: N/D, weight loss, dizziness and fatigue.
◉ restore neurotransmitter loss
Answer: What is the goal for AD medications?
◉ acetylcholine
Answer: What is the primary NT in memory/learning?
◉ Glutamate
Answer: - Most abundant excitatory NT
- Memory/learning
- Too much leads to excitotoxicity which kills nerve cells.
◉ Acetylcholine
Answer: - Memory/learning
- Movement
- Affects sleep-wake cycle
◉ Cholinesterase inhibitors
Answer: - Inhibit cholinesterase from breaking down acetylcholine
- Side effects include GI and bradycardia
- Ex. Donepezil (Aricept): more selective for ACh
, ◉ NMDA receptor Antagonist
Answer: Medication for AD, may slow neurodegeneration
- Blocking NMDA reduces degeneration of the neurons.
◉ Glutamate, NMDA-Glutamate Receptor, NMDA receptor
antagonists, Memantine
Answer: What are some agents that may slow neurodegeneration?
◉ Donepezil
Answer: Cholinesterase inhibitor
- Inhibit cholinesterase from breaking down acetylcholine
- More selective for ACh, so fewer side effects
◉ eating disorders
Answer: Highest rate of any psychiatric disorder; affects men and
women although more common in women; associated with
devastating psychological and physical sequelae.
◉ Anorexia
Answer: Morbid fear of obesity characterized by a preoccupation
with food while refusing to eat.
Does not see behavior as normal
SUMMARY 2026
◉ Amnesia
Answer: Memory impairment
- inability to learn new information recall previously learned
information.
◉ Apraxia
Answer: Inability to carry out motor activities despite intact motor
function.
◉ decrease neuronal loss
Answer: Medication for AD aid to _____________________.
◉ Acetylcholinesterase Inhibitors
Answer: For mild to moderate AD
- Ex. Tacrine, Donepezil, Rivastigmine, Galantamine
◉ Memantine
Answer: For moderate to severe disease; the only approved
medication for Alzheimer disease that is not an AChE inhibitor.
,- SE: N/D, weight loss, dizziness and fatigue.
◉ restore neurotransmitter loss
Answer: What is the goal for AD medications?
◉ acetylcholine
Answer: What is the primary NT in memory/learning?
◉ Glutamate
Answer: - Most abundant excitatory NT
- Memory/learning
- Too much leads to excitotoxicity which kills nerve cells.
◉ Acetylcholine
Answer: - Memory/learning
- Movement
- Affects sleep-wake cycle
◉ Cholinesterase inhibitors
Answer: - Inhibit cholinesterase from breaking down acetylcholine
- Side effects include GI and bradycardia
- Ex. Donepezil (Aricept): more selective for ACh
, ◉ NMDA receptor Antagonist
Answer: Medication for AD, may slow neurodegeneration
- Blocking NMDA reduces degeneration of the neurons.
◉ Glutamate, NMDA-Glutamate Receptor, NMDA receptor
antagonists, Memantine
Answer: What are some agents that may slow neurodegeneration?
◉ Donepezil
Answer: Cholinesterase inhibitor
- Inhibit cholinesterase from breaking down acetylcholine
- More selective for ACh, so fewer side effects
◉ eating disorders
Answer: Highest rate of any psychiatric disorder; affects men and
women although more common in women; associated with
devastating psychological and physical sequelae.
◉ Anorexia
Answer: Morbid fear of obesity characterized by a preoccupation
with food while refusing to eat.
Does not see behavior as normal
